This study infers that, returns generated by the holding company over varied investment periods,...
investments
VREL turned around its business with a 35%/70% growth in revenue/EBITDA in 9MFY24. ...
Our top picks are Rossari Biotech (double digit YoY revenue growth), Ami Organics (volume...
ngel One remains one of the best core portfolio plays on the secular growth...
We initiate coverage of Senco Gold with a TP of Rs1,277 (28x FY26e P/E)....
IHCL has charted a strong growth plan to be achieved by FY2025-26 with a...
The Nifty is trading well within its long-period average P/E of ~20x FY25E EPS....
According to a newsletter issued by Saurabh Mukherjea's Marcellus PMS Fund, the following are...
To benefit from the tailwinds of the above-mentioned trends, we have identified a list...
CELLO is currently trading at 34x FY26E EPS with RoE/RoCE of 32%/39% in FY26E....
